Tags : IPF

Bayer Signs an Exclusive License Agreement with Kyoto University for

Shots: Bayer and Kyoto University collaborate to jointly conduct clinical trials for identifying targets in lung diseases. Bayer will have an exclusive option to license the developed product in the trial The focus of the agreement is to discover targets and develop treatments, with combined techniques of the company in pulmonary disorders including idiopathic pulmonary […]Read More